A Study to Compare the Pharmacokinetics (PK) of Single Subcutaneous (SC) Injections of Vedolizumab Administered in Prefilled Syringe (PFS) Versus (vs) Prefilled Syringe in Autoinjector (PFS+AI) in Healthy Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

204

Participants

Timeline

Start Date

March 12, 2018

Primary Completion Date

October 20, 2018

Study Completion Date

November 21, 2018

Conditions

Healthy Volunteers

Interventions

DRUG

Vedolizumab SC

Vedolizumab SC liquid.

Trial Locations (2)

Celerion, Lincoln

Celerion, Tempe